Form D · Biotechnology
MSKAi, LLC
Memphis, TN · CIK 0001939582
Offering snapshot reported May 19, 2025 · SEC filing
- Reported sold
- $375K Offering amount: $650K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $30K Reported outside-investor minimum
- First sale
- May 1, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 19, 2025 | Initial | $375,000 | No comparison | 1 | SEC filing |
| Aug 1, 2022 | Initial | $625,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-546543
Source: Form D, filed May 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Adam Bruggeman | Executive |
| John Burrow | Executive |
| Jeffrey Engelberg | Executive |
| Screenivas Rangan Sukumar | Executive |
| Chip Wade | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1779 Kirby Parkway, Suite 1 208
Memphis, TN, 38138
Memphis, TN, 38138